Inflation Reduction Act policies need fixing, not celebrating

United States News News

Inflation Reduction Act policies need fixing, not celebrating
United States Latest News,United States Headlines
  • 📰 dcexaminer
  • ⏱ Reading Time:
  • 76 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 94%

This week, the Biden Administration released the first ten medicines that will be subject to price negotiation. These negotiations are possible thanks to the key components in the Inflation Reduction Act (IRA) that was passed last year. While it’s easy to think that this will save money, the hard…

This week, the Biden Administration released the first ten medicines that will be subject to price negotiation. These negotiations are possible thanks to the key components in the Inflation Reduction Act that was passed last year. While it’s easy to think that this will save money, the hard fact is that it probably will not save patients money at all and will actually hurt the drugs that are in development.

The healthcare system in this country surely has its issues. At the same time, having worked with patients from 72 countries, we can say that there is no better country for healthcare anywhere. Anyone who has had a surprise medical bill, has been denied coverage, or had sticker shock at the pharmacy counter can certainly testify about the financial toxicity of healthcare.

The basic truth is that research and development is important if we are to see advancements. That is true in everything from aerospace to alternative energy to drug development. The Biden Administration has made the “Cancer Moonshot” program a major building block in their health care policy, but with the Inflation Reduction Act, they’ve essentially blown it up on the launchpad.

That is why we cannot look at this policy and think that it’s a realistic solution to lowering drug prices. So what is the solution? Let’s start with the pharmacy benefit manager industry. PBMs are just middlemen who use every trick in the book to increase profits and leave patients out in the cold. That is why Congress has an array of bills out there to tackle the PBM industry.

Senators Kyrsten Sinema and Mark Kelly have the opportunity to put the patient voice in their policies. Now that the serious problems of the Inflation Reduction Act are coming into focus, I hope they will turn their attention to fixing the legislation so that we aren’t asking ourselves in twenty years “Where did all the cures go?”

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

dcexaminer /  🏆 6. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

The Inflation Reduction Act Kills the Golden Goose That Could End CancerThe Inflation Reduction Act Kills the Golden Goose That Could End CancerBy vacuuming up drug industry revenue with price controls, Democrats will drive down investment in research and development—and thereby reduce the chance we'll find a cure for cancer.
Read more »

White House on Biden Admitting 'Inflation Reduction Act' Isn't Really About Inflation: It's 'Also About Reducing Prices'White House on Biden Admitting 'Inflation Reduction Act' Isn't Really About Inflation: It's 'Also About Reducing Prices'During an interview with the 'Pod Save America' podcast that took place on Monday and was released on Tuesday, White House Counsel of Economic Advisers | Clips
Read more »

Judge: Trump-era rule change allowing the logging of old-growth forests violates lawsJudge: Trump-era rule change allowing the logging of old-growth forests violates lawsU.S. Magistrate Judge Andrew Hallman on Thursday found that the U.S. Forest Service violated the National Environmental Policy Act, the National Forest Management Act and the Endangered Species Act.
Read more »



Render Time: 2025-03-04 15:15:02